Skip to main content
. 2022 Dec 13;8(2):e002593. doi: 10.1136/rmdopen-2022-002593

Figure 2.

Figure 2

Maximum acceptable risk of mild side effects, serious infection and serious side effects for a reduction in risk of rheumatoid arthritis from 60% to 20%.